How to minimalize antibodies

Christoph Rader ()
Additional contact information
Christoph Rader: The Scripps Research Institute, Jupiter, Florida 33458, USA.

Nature, 2015, vol. 518, issue 7537, 38-39

Abstract: The success of antibodies as pharmaceuticals has triggered interest in crafting much smaller mimics. A crucial step forward has been taken with the chemical synthesis of small molecules that recruit immune cells to attack cancer cells.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/518038a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:518:y:2015:i:7537:d:10.1038_518038a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/518038a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().